Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stoffel, M. P.
Right arrow Articles by Baldamus, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoffel, M. P.
Right arrow Articles by Baldamus, C. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 1082-1083
© 2001 European Renal Association-European Dialysis and Transplant Association

Letters

Radiation nephropathy after radiotherapy in metastatic medullary thyroid carcinoma

M. P. Stoffel1, M. Pollok1, J. Fries2 and C. A. Baldamus1

1 Division of Nephrology Department of Internal Medicine and 2 Institute of Pathology University Hospital of Cologne D-50924 Cologne Germany

Sir,

Moll et al. [1] recently published a case report on the development of thrombotic microangiopathy after irradiation in ovarian malignancy. We would like to report our case of radiation nephropathy developing after ‘internal’ radiotherapy in a female patient with metastatic medullary carcinoma. Radiation nephritis is an inflammatory and degenerative disease of the kidneys after exposure to radioactive substances or body irradiation. Technical development, increasing knowledge of the adverse effects of radiation, and implementation of preventive measures have reduced its incidence during the last decades. However, recent therapeutic advances . . . [Full Text of this Article]

Case.

Discussion.

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNMHome page
M. Behe, G. Kluge, W. Becker, M. Gotthardt, and T. M. Behr
Use of Polyglutamic Acids to Reduce Uptake of Radiometal-Labeled Minigastrin in the Kidneys
J. Nucl. Med., June 1, 2005; 46(6): 1012 - 1015.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. Valkema, S. A. Pauwels, L. K. Kvols, D. J. Kwekkeboom, F. Jamar, M. de Jong, R. Barone, S. Walrand, P. P.M. Kooij, W. H. Bakker, et al.
Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
J. Nucl. Med., January 1, 2005; 46(1_suppl): 83S - 91S.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. Barone, F. Borson-Chazot, R. Valkema, S. Walrand, F. Chauvin, L. Gogou, L. K. Kvols, E. P. Krenning, F. Jamar, and S. Pauwels
Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose-Effect Relationship
J. Nucl. Med., January 1, 2005; 46(1_suppl): 99S - 106S.
[Abstract] [Full Text] [PDF]